Valinomycin induces apoptosis of ascites hepatoma cells (AH-130) in relation to mitochondrial membrane potential

Cell Structure and Function

Volumn 22, Issue 5, 1997, Pages 555-563

  Inai, Yoko ^a   Yabuki, Munehisa ^b   Kanno, Tomoko ^b   Akiyama, Jitsuo ^c   Yasuda, Tatsuji ^a   Utsumi, Kozo ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b University of Tokyo   (Japan)

^c University of Tokyo   (Japan)

Author keywords

AH 130 cells; Bcl 2 family; Caspase 3; Mitochondrial membrane potential; Valinomycin

Indexed keywords

CALCIUM; CELL DNA; DNA FRAGMENT; REACTIVE OXYGEN METABOLITE; VALINOMYCIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; HEPATOMA CELL; LIVER MITOCHONDRION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031439375     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.22.555     Document Type: Article

References (31)

1. ADAM, L., CREPIN, M., SAVIN, C., and ISRAEL, L. 1995. Sodium phenylacetate induces growth inhibition and Bcl-2 down-regulation and apoptosis in MCF7ras cells in vitro and in nude mice. Cancer Res., 55: 5156-5160.
2. AKAO, Y., OTSUKI, Y., KATAOKA, S., ITO, Y., and TSUJIMOTO, Y. 1994. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res., 54: 2468-2471.
3. BURTON, K. 1956. A study of conditions and mechanisms of the diphenylamme reaction for the colorimetic estimation of deoxyribonucleic acid. Biochem. J., 62: 315-323.
4. CHEN, L.Z., NOURSE, J., and CLEARY, M.L. 1989. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t (14; 18) translocation. Mol. Cell Biol., 9: 701-710.
5. COLOFIORE, J.R., STOLFI, R.L., NORD, L.D., and MARTIN, D.S. 1995. Biochemical modulation of tumor cell energy. IV. Evidence for the contribution of adenosine triphosphate (ATP) depletion to chemotherapeutically-induced tumor regression. Biochem. Pharmacol., 50: 1943-1948.
6. DECAUDIN, D., GELEY, S., HIRSCH, T., CASTEDO, M., MARCHETTI, P., MACHO, A., KOFLER, R., and KROEMER, G. 1997. Bcl-2 and Bcl-xL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res., 57: 62-67.
7. ESTABROOK, R. 1967. Mitochondrial respiratory control and the polarographic measurement of ADP: O rations. In Methods in Enzymology, volume X (R.W. Estabrook, and M.E. Pullman, eds.). Academic Press, New York, pp.41-47.
8. GARLAND, J.M. and HALESTRAP, A. 1997. Energy metabolism during apoptosis. J. Biol. Chem., 272: 4680-4688.
9. GONZALEZ, G.M., PEREZ, B.R., DING, L., DUAN, L., BOISE, L.H., THOMPSON, C.B., and NUNEZ, G. 1994. bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development, 120: 3033-3042.
10. HOGEBOOM, G.H. 1955. Fractionation of cell components of animal tissues. In Methods in Enzymology, volume I (S.P. Colowick, and N.O. Kaplan, eds.). Academic Press, New York, pp.16-19.
11. HYSLOP, P.A. and SKLAR, L.A. 1984. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Anal. Biochem., 141: 280-286.
12. 2+-requiring, cyclosporin-sensitive pathway. Biochem. Biophys. Res. Commun., 161: 619-625.
13. JOHNSON, L.V., WALSH, M.L., BOCKUS, B.J., and CHEN, L.B. 1981. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol., 88: 526-535.
14. KLUCK, R.M., BOSSY, W.E., GREEN, D.R., and NEWMEYER, D.D. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 275: 1132-1136.
15. KRIPPNER, A., MATSUNO, Y.A., GOTTLIEB, R.A., and BABIOR, B.M. 1996. Loss of function of cytochrome c in Jurkat cells undergoing Fas-mediated apoptosis. J. Biol. Chem., 271: 21629-21636.
16. LIU, X., KIM, C.N., YANG, J., JEMMERSON, R., and WANG, X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86: 147-157.
17. MARCHETTI, P., HIRSCH, T., ZAMZAMI, N., CASTEDO, M., DEAUDIN, D., SUSIN, S.A., MASSE, B., and KROEMER, G. 1996. Mitochondrial permeability transition triggers lymphocyte apoptosis. J. Immunol., 157: 4830-4836.
18. MARCHETTI, P., SUSIN, S.A., DECAUDIN, D., GAMEN, S., CASTEDO, M., HIRSCH, T., ZAMZAMI, N., NAVAL, J., SENIK, A., and KROEMER, G. 1996. Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res., 56: 2033-2038.
19. MENTZ, F., MOSSALAYI, M.D., OUAAZ, F., BAUDET, S., ISSALY, F., KTORZA, S, SEMICHON, M., BINET, J.L., and MERLE, B.H. 1996. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood, 88: 2172-2182.
20. OJCIUS, D.M., ZYCHLINSKY, A., ZHENG, L.M., and YOUNG, J.D.E. 1991. lonophore-induced apoptosis: Role of DNA fragmentation and calcium fluxes. Exp. Cell Res., 197: 43-49.
21. PETERSEN, A.J., BROWN, R.D., GIBSON, J., POPE, B., LUO, X.F., SCHUTZ, L., WILEY, J.S., and JOSHUA, D.E. 1996. Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro. Eur. J. Haematol., 56: 213-220.
22. PETIT, P.X., SUSIN, S.-A., ZAMZAMI, N., MIGNOTTE, B., and KROEMER, G. 1996. Mitochondria and programmed cell death: back to the future. FEBS Lett., 396: 7-13.
23. RICHTER, C., SCHWEIZER, M., COSSARIZZA, A., and FRANCESCHI, C. 1996. Control of apoptosis by the cellular ATP level. FEBS Lett., 378: 107-110.
24. SEKINE, C., YAGITA, H., KOBATA, T., HASUNUMA, T., NISHIOKA, K., and OKUMURA, K. 1996. Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biochem. Biophys. Res. Commun., 228: 14-20.
25. SHIMIZU, S., EGUCHI, Y., KAMIIKE, W., WAGURI, S., UCHIYAMA, Y., MATSUDA, H., and TSUJIMOTO, Y. 1996. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene, 13: 21-29.
26. SKULACHEV, V.P. 1996. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cells. FEBS Lett., 397: 7-10.
27. SUSIN, S.A., ZAMZAMI, N., CASTEDO, M., HIRSCH, T., MARCHETTI, P., MACHO, A., DAUGAS, E., GEUSKENS, M., and KROEMER, G. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 184: 1331-1341.
28. TANGYE, S.O. and RAISON, R.L. 1996. Leukaemic CD5+ B-cell apoptosis: co-incidence of cell death and DNA fragmentation with reduced bcl-2 expression. Br. J. Haematol., 92: 950-953.
29. YANG, J., LIU, X., BHALLA, K., KIM, C.N., IBRADO, A.M., CAI, J., PENG, T.I., JONES, D.P., and WANG, X. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275: 1129-1132.
30. ZAMZAMI, N., MARCHETTI, P., CASTEDO, M., HIRSCH, T., SUSIN, S.A., MASSE, B., and KROEMER, G. 1996. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett., 384: 53-57.
31. ZHU, W., COWIE, A., WASFY, G., PENN, L., LEBER, B., and ANDREWS, D. 1996. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J., 15: 4130-4141.